文献速递关节外科

关节腔内与静脉应用氨甲环酸减少全膝关节置换术围手术期失血的疗效与安全性:前瞻性随机双盲等效性试验

Efficacy and safety of intra-articular versus intravenous tranexamic acid in reducing perioperative blood loss in total knee arthroplasty: a prospective randomized double-blind equivalence trial.
PubMed 文献 · Bone Joint J · 2018-01-01

这项前瞻性随机双盲等效性试验纳入182例45至75岁接受单侧全膝关节置换术的患者,比较关节腔内注射1.5 g氨甲环酸(n=91)与静脉注射两剂10 mg/kg氨甲环酸(n=91)的疗效与安全性。主要结局为术后第五天血红蛋白下降水平,两组均差为-0.0055 gm/dl(95%CI -0.29至0.27),落在预设等效界值±0.35 gm/dl内。两组总失血量、可见失血量、隐藏失血量及并发症相当,无患者需要输血,结论为两种给药途径等效。

要点

  • 关节腔内1.5 g与静脉两剂10 mg/kg氨甲环酸在减少全膝关节置换术失血方面等效。
  • 两组术后第五天血红蛋白下降均差-0.0055 gm/dl(95%CI -0.29至0.27),在±0.35 gm/dl等效界值内。
  • 两组总失血量、可见失血量、隐藏失血量及并发症相当,无患者需要输血。

核心结论

  • 单次关节腔内给药与两次静脉给药氨甲环酸在全膝关节置换术失血管理中疗效与安全性等效。

研究设计与样本

  • 前瞻性随机双盲等效性试验,共纳入182例45至75岁在三级中心接受单侧全膝关节置换术的患者。
  • 患者随机接受关节腔内1.5 g氨甲环酸(n=91)或静脉两剂10 mg/kg氨甲环酸(n=91)。
  • 采用计算机生成随机数的区组随机化,患者与结局评估者设盲。
  • 主要结局为术后第五天血红蛋白下降水平,预设等效界值为±0.35 gm/dl。

主要发现

  • 两组血红蛋白下降均差为-0.0055 gm/dl,双侧95%CI为-0.29至0.27,落在预设等效界值±0.35 gm/dl内。
  • 两组总失血量、可见失血量、隐藏失血量及并发症相当。
  • 无患者需要输血。
  • 所有患者均完成研究。

关键数值与推荐

  • 主要结局等效界值为±0.35 gm/dl。
  • 关节腔内组氨甲环酸剂量为1.5 g,于伤口关闭后给药。
  • 静脉组氨甲环酸剂量为两剂10 mg/kg。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The aims of this study were to compare the efficacy and safety of intra-articular and intravenous (IV) tranexamic acid (TXA) in controlling perioperative blood loss in total knee arthroplasty (TKA) using a randomized, double-blinded equivalence trial. PATIENTS AND METHODS: A total of 182 patients aged between 45 and 75 years undergoing unilateral TKA at a tertiary centre were randomized to receive TXA, either 1.5 g intra-articularly after closure of the wound (n = 91) or two doses of 10 mg/kg IV (n = 91). The primary outcome measure was the reduction in the level of haemoglobin (Hb) in the blood on the fifth postoperative day. Secondary outcome measures were the total, visible, and hidden blood losses (TBL, VBL, HBL). We assumed equivalence of the primary outcome in both routes with a margin of ± 0.35gm/dl. Block randomization using computer-generated random numbers was used. The patients and the assessor of outcome were blinded. RESULTS: All patients completed the study. The mean difference in the reduction of the level of Hb between the two groups was -0.0055 gm/dl, with two-sided 95% confidence interval (CI) being -0.29 to 0.27, well within the predefined equivalence margin of ± 0.35gm/dl. The groups were comparable with regard to TBL, VBL, HBL, and complications. No patient needed a blood transfusion. CONCLUSION: A single intra-articular dose and two IV doses of TXA give equivalent efficacy and safety in the management of blood loss at TKA. Cite this article: Bone Joint J 2018;100-B:152-60.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Subramanyam KN, Khanchandani P, Tulajaprasad PV, et al. Efficacy and safety of intra-articular versus intravenous tranexamic acid in reducing perioperative blood loss in total knee arthroplasty: a prospective randomized double-blind equivalence trial. Bone Joint J. 2018. PMID: 29437056. doi:10.1302/0301-620X.100B2.BJJ-2017-0907.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。